Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$453.82M-24.4%-$364.89M-19.6%-$305.21M-23.2%-$247.79M-16.1%-$213.42M-9.7%
$2.35M+3.5%$2.27M+9.9%$2.06M+17.3%$1.76M+3.9%$1.69M-2.5%
$87.3M+159%$33.7M+9.5%$30.78M+6.8%$28.83M+14.9%$25.08M+11.8%
-$354.17M-29.1%-$274.24M-32.3%-$207.31M+6.5%-$221.76M-14.1%-$194.44M-40.6%
$1.54M-20.1%$1.93M-42.5%$3.35M-55.0%$7.45M+128%$3.27M+167%
$172.62M+131%$74.88M+201%$24.85M-27.5%$34.28M+315%-$15.95M+95.9%
$238.74M-34.7%$365.66M$0-100%$256.58M+29,257%$874K-99.9%
$57.19M-$184.05M-$209.51M
-$355.7M-28.8%-$276.16M-31.1%-$210.66M+8.1%-$229.21M-15.9%-$197.7M-41.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Revolution Medicines, Inc. generate?
Revolution Medicines, Inc. (RVMD) generated -$1.1B in operating cash flow over the trailing twelve months.
What is Revolution Medicines, Inc.'s free cash flow?
After $14.3M of capital expenditures, Revolution Medicines, Inc.'s free cash flow was -$1.1B over the trailing twelve months, down 78.1% year over year.
Where does Revolution Medicines, Inc.'s cash flow data come from?
Every line is extracted from Revolution Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.